CDKN1A and head and neck squamous cell carcinoma: In summary, we have identified a therapeutic signaling loop in which the level of elevated ROS is determinate when leading to the activation of partially functional p53, causing long-term expression of p21 that sustains ROS at these elevated levels, inducing HNSCC cells to undergo cell death through a senescence pathway.